Eliminating Intensive Postoperative Care in Same-day Surgery Patients Using Short-acting Anesthetics

Background: A multidisciplinary effort was undertaken to determine whether patients could safely bypass the postanesthesia care unit (PACU) after same-day surgery by moving to an earlier time point evaluation of recovery criteria.

Methods: A prospective, outcomes research study with a baseline month, an intervention month, and a follow-up month was designed. Five surgical centers (three community-based hospitals and two freestanding ambulatory surgical centers) were utilized. Two thousand five hundred eight patients were involved in the baseline period, and 2,354 were involved in the follow-up period. Outcome measures included PACU bypass rates and adverse events. Intervention consisted of a multidisciplinary educational program and routine feedback reports.

Results: The overall PACU bypass rate (58%) was significantly different from baseline (15.9%, P < 0.001), for patients to whom a general anesthetic was administered (0.4-31.8%, P < 0.001), and for those given other anesthetic techniques (monitored anesthesia care, regional or local anesthetics; 29.1-84.2%, P < 0.001). During the follow-up period, the average (SD) recovery duration for patients who bypassed the PACU was significantly shorter compared to that for patients who did not bypass, 84.6 (61.5) versus 175.1 (98.8) min, P < 0.001, with no change in patient outcome. Patients receiving only short-acting anesthetics were 78% more likely (P < 0.002) to bypass the PACU after adjusting for various surgical procedures.     

子宫肌瘤经子宫动脉栓塞术治疗后患者满意度和生活质量调查

目的:评估子宫肌瘤患者经子宫动脉栓塞术(UAE)治疗后临床症状严重程度、健康相关生活质量(HRQOL)的变化及对治疗满意度的调查。设计:对1998～2002年80例经UAE治疗的子宫肌瘤患者进行问卷调查,了解治疗的有效性、治疗前后的临床症状严重程度及HRQOL的变化。主要观察指标:UAE治疗后症状严重程度及HRQOL评分的变化。次要观察指标:患者满意度及子宫体积缩小程度。结果:64例(80.0%)患者完成了问卷,调查时间为UAE后平均32.1月(范围:57.5～6月)。UAE后子宫体积平均缩小26.3%(95%CI19.6～33.0),79例患者中17例(21.5%)于术后平均18.6月…     

A Phase III, Double-blind, Placebo-controlled, Multicenter Study on the Efficacy of Recombinant Human Antithrombin in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

Background: The study evaluated the efficacy of recombinant human antithrombin (rhAT) for restoring heparin responsiveness in heparin resistant patients undergoing cardiac surgery.

Methods: This was a multicenter, randomized, double-blind, placebo-controlled study in heparin-resistant patients undergoing cardiac surgery with cardiopulmonary bypass. Heparin resistance was diagnosed when the activated clotting time was less than 480 s after 400 U/kg heparin. Fifty-four heparin-resistant patients were randomized. One cohort received 75 U/kg rhAT, and the other received normal saline. If the activated clotting time remained less than 480 s, this was considered treatment failure, and 2 units fresh frozen plasma was transfused. Patients were monitored for adverse events.

Results: Only 19% of patients in the rhAT group received fresh frozen plasma, compared with 81% of patients in the placebo group (P < 0.001). During their hospitalization, 48% of patients in the rhAT group received fresh frozen plasma, compared with 85% of patients in the placebo group (P = 0.009). Patients in the placebo group required higher heparin doses (P < 0.005) for anticoagulation. There was no increase in serious adverse events associated with rhAT. There was increased blood loss 12 h postoperatively (P = 0.05) with a trend toward increased 24-h bleeding in the rhAT group (P = 0.06). There was no difference between the groups in blood and platelet transfusions.     

南阳地区5岁以下儿童社区获得性肺炎病原菌检测分析

目的通过对南阳地区≤5岁儿童社区获得性肺炎(CAP)患儿下呼吸道分泌物病原菌的检测，探讨近年儿童CAP病原菌构成和耐药谱的新特点。 方法选择2003 11—2005 12来自南阳地区各不同社区于南阳医专附院儿科就诊，符合肺炎诊断标准的儿童CAP住院患者1276例，用多平板不同条件对未抗菌治疗采得的标本进行接种培养，分离菌株采用Bio Merieux VITEK 2型全自动微生物仪进行菌种鉴定和药物敏感试验，结果采用WHONET5软件分析处理，得出儿童CAP病原菌种分布构成比及主要致病菌种对常用抗菌药物的耐药率。 结果检出病原菌以革兰阴性菌为主，占68.6%(297/433)，其中前3位分别为大肠埃希菌、肺炎克雷伯菌及铜绿假单胞菌。6种主要革兰阴性菌对氨苄西林、复方磺胺、头孢唑啉显示高抗药性，而对美洛培南、亚安培南高度敏感，对阿米卡星、头孢吡肟较敏感。4种主要革兰阳性菌对万古霉素高度敏感，对利福平、氨苄西林/舒巴坦及左氧氟沙星较敏感。 结论儿童CAP病原菌构成在发生变迁，细菌的耐药性也在发生改变，且各地及不同时期存在差异，故应作好病原及药敏监测并改进检测方法，掌握本地区一定时期内儿童CAP的病原学情况。     

栓塞回流静脉加平阳霉素注射治疗巨大海绵状血管瘤

硬化剂瘤腔内注射治疗海绵状血管瘤已广泛应用于临床，但对于巨大漫无边界的海绵状血管瘤，因其回流静脉非常丰富，常导致注射后大部分硬化剂很快流失，治疗效果常不肯定，是目前临床上非常棘手的难题之一。自1996年以来，笔者对25例不同部位较大的无明显边界的海绵状血管瘤进行了栓塞加硬化或栓塞硬化加手术切除治疗，疗效满意，现报道如下。     

睡眠障碍可能是发生男性心肌梗死的一个危险因素

[俄]/ГаФаров ВВ…//Клин Мед.—2006,84(4).—28～30睡眠是机体的自然生理状态,对保持机体各器官和系统的正常功能十分重要;而睡眠障碍则是影响健康的因素之一。根据世界卫生组织专家委员会关于研究睡眠障碍的资料,美国有36%成年人睡眠不正常,有4千万人患慢性     

MRI诊断腰骶部椎管内包虫病1例

1 病历简介 患者,男,60岁.腰痛、双下肢疼痛进行性加重8个月,并逐渐出现双下肢活动及大小便功能障碍.查体:腰4以下感觉减退,双下肢肌力4级.双侧巴彬斯基征( ),双侧踝阵挛( ).曾于7年前做过肝包虫内囊摘除术.肝脏B超:肝右后叶见一不均质的囊性占位性病变,诊断为肝右后叶包虫术后残腔并复发. MRI检查所见:腰3椎体下缘至骶2椎体上缘水平椎管内见多房性有分隔的长T2长T1囊性异常信号,分隔于T2WI呈低信号,T1WI呈相对稍高信号(图1,2),增强扫描不增强.病变沿腰5～骶1左侧椎间孔、骶1～2左侧骶前孔向盆腔内生长,骶1、2椎体有骨质破坏吸收(图3).     

Effects of Volatile Anesthetics on Glutamate Transporter, Excitatory Amino Acid Transporter Type 3: The Role of Protein Kinase C

Background: Glutamate transporters play an important role in maintaining extracellular glutamate homeostasis. The authors studied the effects of volatile anesthetics on one type of glutamate transporters, excitatory amino acid transporter type 3 (EAAT3), and the role of protein kinase C in mediating these effects.

Methods: Excitatory amino acid transporter type 3 was expressed in Xenopus oocytes by injection of EAAT3 mRNA. Using two-electrode voltage clamp, membrane currents were recorded before, during, and after application of l-glutamate. Responses were quantified by integrating the current trace and are reported as microcoulombs. Data are mean +/- SEM.

Results: l-Glutamate-induced responses were increased gradually with the increased concentrations of isoflurane, a volatile anesthetic. At 0.52 and 0.70 mm isoflurane, the inward current was significantly increased compared with control. Isoflurane (0.70 mm) significantly increased Vmax (maximum velocity) (3.6 +/- 0.4 to 5.1 +/- 0.4 [mu]C;P < 0.05) but not Km (Michoelis-Menten Constant) (55.4 +/- 17.0 vs. 61.7 +/- 13.6 [mu]m;P > 0.05) of EAAT3 for glutamate compared with control. Treatment of the oocytes with phorbol-12-myrisate-13-acetate, a protein kinase C activator, caused a significant increase in transporter current (1.7 +/- 0.2 to 2.5 +/- 0.2 [mu]C;P < 0.05). Responses in the presence of the combination of phorbol-12-myrisate-13-acetate and volatile anesthetics (isoflurane, halothane, or sevoflurane) were not greater than those when volatile anesthetic was present alone. Oocytes pretreated with any of the three protein kinase C inhibitors alone (chelerythrine, staurosporine, or calphostin C) did not affect basal transporter current. Although chelerythrine did not change the anesthetic effects on the activity of EAAT3, staurosporine or calphostin C abolished the anesthetic-induced increase of EAAT3 activity.     

呼吸道真菌感染148例临床特点及防治对策

在我院2000年1月至2006年7月住院患者中有呼吸道真菌感染148例。现将其临床特点及防治对策报告如下。